Abstract
The serotonin transporter (SERT) belongs to a family of sodium- and chloride-dependent neurotransmitter transporters that are responsible for the active re-uptake of the neurotransmitter serotonin from the synapse. In the present study, using the yeast two-hybrid system, we identified the membrane glycoprotein M6B as a binding partner of SERT. This interaction was further verified by co-immunoprecipitation and glutathione-S-transferase pull-down assays. M6B belongs to a proteolipid protein family, which is expressed in neurons and in oligodendrocytes in the brain. The knowledge of the biological function of this protein family is sparse, but their expression in most brain regions have led to the hypothesis that they are involved in cellular housekeeping functions such as membrane trafficking and cell-to-cell communication. The co-expression of SERT with M6B results in a significant decrease in SERT-mediated serotonin uptake caused by a down-regulation of SERT surface expression. Furthermore, we find, using confocal microscopy, that M6B co-localizes with SERT when transiently expressed in HEK-MSR-293 cells and when endogenously expressed in RN46A cells. Taken together, our data suggest that M6B regulates the serotonin uptake by affecting cellular trafficking of the serotonin transporter.
Similar content being viewed by others
Abbreviations
- SERT:
-
serotonin transporter
- DAT:
-
dopamine transporter
- NET:
-
norephinephrine transporter
- 5-HT:
-
serotonin
- SCAMP-2:
-
secretory carrier associated membrane protein
- PLP:
-
proteolipid protein
- TM1:
-
transmembrane domain 1
- PBS:
-
phosphate-buffered saline
- HEK-MSR-293:
-
human embryonic kidney-293
- RN46A:
-
immortalized raphe nucleus cells
References
Blakely, R. D., Berson, H. E., Fremeau, R. T., Jr., Caron, M. G., Peek, M. M., Prince, H. K., et al. (1991). Cloning and expression of a functional serotonin transporter from rat brain. Nature, 354, 66–70.
Celik, L., Sinning, S., Severinsen, K., Hansen, C. G., Møller, M. S., Bols, M., et al. (2008). Binding of serotonin to the human serotonin transporter. Molecular modelling and experimental validation. Journal of the American Chemical Society, 130, 3853–3865.
Chanrion, B., Mannoury la Cour, C., Bertase, B., Lerner-Natoli, M., Freissmuth, M., Millan, M. J., et al. (2007). Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. PNAS, 104, 8119–8124.
Haase, J., Killian, A. M., Magnani, F., & Williams, C. (2001). Regulation of the serotonin transporter by interacting proteins. Biochemical Society Transactions, 29, 722–728.
Henneke, M., Wehner, L. E., Hennies, H. C., Preuss, N., & Gartner, J. (2004). Mutation analysis of the M6b gene in patients with Pelizaeus-Merzbacher-like syndrome. American Journal of Medical Genetics A, 128, 156–158.
Hipolide, D. C., Moreira, K. M., Barlow, K. B., Wilson, A. A., Nobrega, J. N., & Tufik, S. (2005). Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 297–303.
Hoffman, B. J., Mezey, E., & Brownstein, M. J. (1991). Cloning of a serotonin transporter affected by antidepressants. Science, 254, 579–580.
Jimerson, D. C., Lesem, M. D., Kaye, W. H., Hegg, A. P., & Brewerton, T. D. (1990). Eating disorders and depression: Is there a serotonin connection? Biological Psychiatry, 5, 443–454.
Knapp, P. E., Benjamins, J. A., & Skoff, R. P. (1996). Epigenetic factors up-regulate expression of myelin proteins in the dysmyelinating jimpy mutant mouse. Journal of Neurobiology, 29(2), 138–150.
Magnani, F., Tate, C. G., Wynne, S., Williams, C., & Haase, J. (2004). Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. Journal of Biological Chemistry, 279, 38770–38778.
Mortensen, O. V., Kristensen, A. S., Rudnick, G., & Wiborg, O. (1999). Molecular cloning, expression and characterization of a bovine serotonin transporter. Molecular Brain Research, 71(1), 120–126.
Müller, H. K., Wiborg, O., & Haase, J. (2006). Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2. Journal of Biological Chemistry, 281, 28901–28909.
Murphy, D. L., Lerner, A., Rudnick, G., & Lesch, K. P. (2004). Serotonin transporter: Gene, genetic disorders, and pharmacogenetics. Molecular Interventions, 4, 109–123.
Nadon, N. L., Miller, S., Draeger, K., & Salvaggio, M. (1997). Myelin proteolipid DM20: Evidence for function independent of myelination. International Journal of Developmental Neuroscience, 15, 285–293.
Nave, K. A., Lai, C., Bloom, F. E., & Milner, R. J. (1987). Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proceedings of the National Academy of Sciences of the United States of America, 84, 5665–5669.
Qian, Y., Galli, A., Ramamoorthy, S., Risso, S., DeFelice, L. J., & Blakely, R. D. (1997). Protein kinase C activation regulates human serotonin transporters in HEK-MSR-293 cells via altered cell surface expression. Journal of Neuroscience, 17, 45–57.
Quick, M. W. (2003). Regulating the conducting states of a mammalian serotonin transporter. Neuron, 40, 537–549.
Ramamoorthy, S., Bauman, A. L., Moore, K. R., Han, H., Yang-Feng, T., Chang, A. S., et al. (1993). Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proceedings of the National Academy of Sciences of the United States of America, 90, 2542–2546.
Ramamoorthy, S., & Blakely, R. D. (1999). Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science, 285, 763–766.
Rudnick, G., & Clark, J. (1993). From synapse to vesicle – the reuptake and storage of biogenic-amine neurotransmitters. Biochimica et Biophysica Acta, 1144, 249–263.
Schloss, P., & Williams, D. C. (1998). The serotonin transporter: A primary target for antidepressant drugs. Journal of Psychopharmacology, 12, 115–121.
Serretti, A., Calati, R., Mandelli, L., & De Ronchi, D. (2006). Serotonin transporter gene variants and behavior: A comprehensive review. Current Drug Targets, 7, 1659–1669.
Shimokawa, N., & Miura, M. (2000). Rhombex-29, a novel gene of the PLP/DM20-M6 family cloned from rat medulla oblongata by differential display. Journal of Neuroscience Research, 62, 1–8.
Sidhu, A., Wersinger, C., & Vernier, P. (2004). Alpha-Synuclein regulation of the dopaminergic transporter: A possible role in the pathogenesis of Parkinson’s disease. FEBS Letters, 565, 1–5.
Simons, M., Kramer, E. M., Macchi, P., Rathke-Hartlieb, S., Trotter, J., Nave, K. A., et al. (2002). Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: Implications for Pelizaeus-Merzbacher disease. Journal of Cell Biology, 157, 327–336.
Tatsumi, M., Jansen, K., Blakely, R. D., & Richelson, E. (1999). Pharmacological profile of neuroleptics at human monoamine transporters. European Journal of Pharmacology, 368, 277–283.
Torres, G. E. (2006). The dopamine transporter proteome. Journal of Neurochemistry, 97, 3–10.
Uhl, G. R. (1992). Neurotransmitter transporters (plus): A promising new gene family. Trends in Neurosciences, 15, 265–268.
Vouyiouklis, D. A., Werner, H., Griffiths, I. R., Stewart, G. J., Armin-Nave, K., & Thomson, C. E. (1998). Molecular cloning and transfection studies of M6b-2, a novel splice variant of a member of the PLP-DM20/M6 gene family. Journal of Neuroscience Research, 52, 633–640.
Werner, H., Dimou, L., Klugmann, M., Pfeiffer, S., & Nave, K. A. (2001). Multiple splice isoforms of proteolipid M6B in neurons and oligodendrocytes. Molecular and Cellular Neurosciences, 18, 593–605.
Wersinger, C., Jeannotte, A., & Sidhu, A. (2006a). Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein. European Journal of Neuroscience, 24, 3141–3152.
Wersinger, C., Rusnak, M., & Sidhu, A. (2006b). Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. European Journal of Neuroscience, 24, 55–64.
Wersinger, C., & Sidhu, A. (2005). Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry, 44, 13612–13624.
Wu, D. F., Koch, T., Liang, Y., Stumm, R., Schulz, S., Schröder, H., et al. (2007). Membrane glycoprotein M6A interacts with the μ-opioid receptor and facilitates receptor endocytosis and recycling. Journal of Biological Chemistry, 282, 22239–22247.
Yamashita, A., Singh, S. K., Kawate, T., Jin, Y., & Gouaux, E. (2005). Crystal structure of a bacterial homologue of Na+/Cl-dependent neurotransmitter transporters. Nature, 473, 215–222.
Yan, Y., Narayanan, V., & Lagenaur, C. (1996). Expression of members of the proteolipid protein gene family in the developing murine central nervous system. Journal of Comparative Neurology, 370, 465–478.
Acknowledgments
The work was partly carried out during an extended stay by A.W. Fjorback in the lab of Jana Haase, School of Biomolecular and Biomedical Sciences, Conway Institute, University of College Dublin, Ireland; we are grateful for her supervision and assistance. We thank Karina Birk Nygaard for her technical assistance. We are grateful to Dr. H. Werner, for providing antibodies and the M6B plasmid, and to Dr. Narayanan, for providing the M6A plasmids. This work was supported by the EU Marie Curie Molecular Neuroimmunology PhD Programme (MNIEST, contract number MEST-CT-514333), UCD Conway Institute, Dublin, Ireland and Eli Lilly Foundation, Denmark.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fjorback, A.W., Müller, H.K. & Wiborg, O. Membrane Glycoprotein M6B Interacts with the Human Serotonin Transporter. J Mol Neurosci 37, 191–200 (2009). https://doi.org/10.1007/s12031-008-9092-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9092-4